Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer's disease.

Musicco M, Palmer K, Russo A, Caltagirone C, Adorni F, Pettenati C, Bisanti L.

Dement Geriatr Cogn Disord. 2011;31(3):218-24. doi: 10.1159/000326213. Epub 2011 Apr 6.

2.

Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.

Suh DC, Arcona S, Thomas SK, Powers C, Rabinowicz AL, Shin H, Mirski D.

Drugs Aging. 2004;21(6):395-403.

PMID:
15084141
3.

Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.

López-Pousa S, Olmo JG, Franch JV, Estrada AT, Cors OS, Nierga IP, Gelada-Batlle E.

Age Ageing. 2006 Jul;35(4):365-71.

PMID:
16788079
4.

Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.

Lanari A, Amenta F, Silvestrelli G, Tomassoni D, Parnetti L.

Mech Ageing Dev. 2006 Feb;127(2):158-65. Epub 2005 Nov 16. Review.

PMID:
16297434
5.

Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity.

Gardette V, Lapeyre-Mestre M, Coley N, Cantet C, Montastruc JL, Vellas B, Andrieu S.

Curr Alzheimer Res. 2012 Nov;9(9):1106-16.

PMID:
22950915
6.

Current issues in dementia pharmacotherapy.

Daiello LA.

Am J Manag Care. 2007 Dec;13 Suppl 8:S198-202. Review.

7.

Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA.

N Engl J Med. 2005 Dec 1;353(22):2335-41.

8.

All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study.

Liperoti R, Onder G, Landi F, Lapane KL, Mor V, Bernabei R, Gambassi G.

J Clin Psychiatry. 2009 Oct;70(10):1340-7. doi: 10.4088/JCP.08m04597yel.

9.

The influence of psychotropic drugs on cerebral cell death: female neurovulnerability to antipsychotics.

Bonelli RM, Hofmann P, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G, Kapfhammer HP.

Int Clin Psychopharmacol. 2005 May;20(3):145-9.

PMID:
15812264
11.

Antipsychotic drug use and mortality in older adults with dementia.

Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA.

Ann Intern Med. 2007 Jun 5;146(11):775-86.

PMID:
17548409
12.

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J.

Drugs Aging. 2004;21(7):453-78. Review.

PMID:
15132713
13.

Pharmacological treatment of Alzheimer's Disease.

Bianchetti A, Ranieri P, Margiotta A, Trabucchi M.

Aging Clin Exp Res. 2006 Apr;18(2):158-62. Review.

PMID:
16702787
14.
15.

Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease.

Amuah JE, Hogan DB, Eliasziw M, Supina A, Beck P, Downey W, Maxwell CJ.

Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):670-9. doi: 10.1002/pds.1946.

PMID:
20583207
16.

The use of atypical antipsychotics in nursing homes.

Liperoti R, Mor V, Lapane KL, Pedone C, Gambassi G, Bernabei R.

J Clin Psychiatry. 2003 Sep;64(9):1106-12.

PMID:
14628988
17.

Pharmacotherapy for behavioral and psychological symptoms of dementia in the elderly.

Beier MT.

Am J Health Syst Pharm. 2007 Jan 15;64(2 Suppl 1):S9-17; quiz S24-5.

PMID:
17215476
18.

[Biological therapies of behavioral and psychological symptoms of dementia: update and prospects].

Gallarda T, Olie JP.

Encephale. 2000 May-Jun;26(3):72-80. Review. French.

PMID:
10951909
19.

Cholinesterase inhibitors for Alzheimer disease: do they provide more than symptomatic benefits?

Suh GH, Ryu SH, Lee DW, Han C, Ju YS, Kee BS, Lee JN, Bae JN, Choi JH, Kim DJ, Lee NJ, Lee JY, Go HJ, Yi JS, Cho SJ, Jeon YW.

Am J Geriatr Psychiatry. 2011 Mar;19(3):266-73. doi: 10.1097/JGP.0b013e3181e56d30.

PMID:
20808128
20.

Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications.

Setoguchi S, Wang PS, Alan Brookhart M, Canning CF, Kaci L, Schneeweiss S.

J Am Geriatr Soc. 2008 Sep;56(9):1644-50. doi: 10.1111/j.1532-5415.2008.01839.x. Epub 2008 Aug 4.

PMID:
18691283

Supplemental Content

Support Center